BIBLIOGRAFIA

1. Dummer, R., et al., Ann Oncol, 2015. 26 Suppl 5: p. v126-32.
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

2. SEER Stat Fact Sheets: Melanoma of the Skin.

3. Clark, L.N., et al., Journal of the American Academy of Dermatology. 56(5): p. 768-773.
Association between the anatomic distribution of melanoma and sex.

4. DeVita V, L.T., Rosenberg S., 9th ed. 2011.
Cancer principles and practice of Oncology.

5. Green, A.C., et al., J Clin Oncol, 2011. 29(3): p. 257-63.
Reduced melanoma after regular sunscreen use: randomized trial follow-up.

6. Shain, A.H., et al., N Engl J Med, 2015. 373(20): p. 1926-36.
The Genetic Evolution of Melanoma from Precursor Lesions.

7. Garbe, C., et al., European Journal of Cancer, 2012. 48(15): p. 2375-2390.
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012.

8. Scope, A., et al., Archives of Dermatology, 2008. 144(1): p. 58-64.
The “ugly duckling” sign: Agreement between observers.

9. Brehmer, F., M. Ulrich, and H.A. Haenssle, Dermatology Practical & Conceptual, 2012. 2(3): p. 0203a06.
Strategies for early recognition of cutaneous melanoma - present and future.

10. Balch, C.M., et al., Journal of Clinical Oncology, 2009. 27(36): p. 6199-6206.
Final Version of 2009 AJCC Melanoma Staging and Classification.

11. Naeyaert , J.M. and L. Brochez, New England Journal of Medicine, 2003. 349(23): p. 2233-2240.
Dysplastic Nevi.

12. National Comprehensive Cancer Guidelines (NCCN) Version 2.2016.

13. Eigentler, T.K., et al., Cancer, 2011. 117(8): p. 1697-703.
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.

14. Marsden, J.R., et al., British Journal of Dermatology, 2010. 163(2): p. 238-256.
Revised U.K. guidelines for the management of cutaneous melanoma 2010.

15. Hong, A. and G. Fogarty, Cancer J, 2012. 18(2): p. 203-7.
Role of radiation therapy in cutaneous melanoma.

16. Hauswald, H., et al., Radiation Oncology (London, England), 2012. 7: p. 130-130.
Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma.

17. Lippitz, B., et al., Cancer Treatment Reviews, 2014. 40(1): p. 48-59.
Stereotactic radiosurgery in the treatment of brain metastases: The current evidence.

18. Sondak, V.K. and S.A. Leachman, Journal of Clinical Oncology, 2011. 29(35): p. 4606-4608.
Individualizing Follow-Up for Patients With Early-Stage Melanoma.

19. Cromwell, K.D., et al., Melanoma research, 2012. 22(5): p. 10.1097/CMR.0b013e328357d796.
Variability in melanoma post-treatment surveillance practices by country and physician specialty: A systematic review.

20. Trotter, S.C., et al., The Journal of Clinical and Aesthetic Dermatology, 2013. 6(9): p. 18-26.
A Global Review of Melanoma Follow-up Guidelines.

Este site e o seu conteúdo têm um fim exclusivamente informativo e não substituem o aconselhamento médico. Os tratamentos de cada pessoa devem ser individualizados e conduzidos por profissionais de saúde, sendo o médico que acompanha o doente quem poderá indicar qual o tratamento adequado a cada caso. As instruções do médico e dos restantes profissionais de saúde que o acompanham devem ser rigorosamente seguidas, pelo que sugerimos que contacte sempre o seu médico.